Biofil Chem & Pharma Ltd
₹34.40
-6.50%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.14.
- Comfortable interest cover: operating profit covers interest about 65 times.
- Net profit margin is 9.8%.
- Profit has compounded about 18% a year over five years.
- Promoters hold a sizeable stake (46.79%).
!Watch-points
- Return on equity is on the lower side at -2.8%.
- Return on capital employed is on the lower side at 3%.
- Sales growth has been slow over five years (about -5% a year).
- Recent profit growth (-83%) is slower than the five-year pace (18%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.67
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 56 Cr
Current Price₹ 34.40
High / Low₹ 46.34 / 25.60
Stock P/E114.666664
Book Value₹ 13.20
Dividend Yield0%
ROCE2.97%
ROE-2.83%
Face Value₹ 10.00
Debt to Equity0.14
PEG Ratio1.65
EV / EBITDA64.37
Industry PE35.70
P/B Ratio2.6038907
EPS₹ 1.71
Debt₹ 3 Cr
PAT Margin9.82%
Cash PAT₹ 3 Cr
ICR65.00
Promoter Holding46.79%
FII Holding0.00%
DII Holding0.08%
Public Holding53.13%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity